论文部分内容阅读
B型肝炎即所谓血清肝炎有可能导致慢性肝病、肝硬化、甚至肝癌。现在,征服这种肝炎已不是那么遥远的事了。美国纽约血液中心的斯麦奈司(W.Szmuness)博士等人所进行的肝炎病毒疫苗的大规模临床试验的成功,给我们带来了很大的希望。这个研究由《新英国医药杂志》1980年10月9日一期上发表,继由《自然》1980年10月9日一期和《科学》1980年11月14日一期上对此作了介绍。从血清肝炎往往发病于输血时这一点出发,其另一个名称也叫作输血肝炎。这是一种不经过口腔,由于使用了消毒不完全的注射器、性的接触或昆虫的媒介等而感染的疾病。感染之后,有不少是长期
Hepatitis B, the so-called hepatitis, may cause chronic liver disease, cirrhosis and even liver cancer. It is not so far to conquer this kind of hepatitis. The success of the large-scale clinical trial of the hepatitis B virus vaccine by Dr. W. Szmuness at the New York Blood Center in the United States has given us great hope. This study was published in the New England Journal of Medicine on October 9, 1980, followed by Nature, October 9, 1980, and Science, November 14, 1980 Introduction. From the point of view that serum hepatitis is often associated with blood transfusions, another name is also called blood transfusion hepatitis. This is a disease that does not pass through the mouth, due to the use of incomplete disinfection of syringes, sexual contact or insect media and other infections. After infection, many are long-term